Original study
Prognostic indicators of chronic chagasic cardiopathy

https://doi.org/10.1016/0167-5273(91)90095-7Get rights and content

Abstract

After 104 patients with positive serology for Chagas' disease had been followed for a decade, a selection of 66 patients was made from this number and a total of 25 variables obtained from clinical and paraclinical findings were analyzed, with the purpose of knowing which of these variables may be of help, in time, in determining prognosis. The information was analyzed using the Cox regression model. The patients were classified into groups according to the results in the invasive and noninvasive studies: those with a normal electrocardiogram without heart disease (14 patients) or with early segmental abnormalities of the left ventricle (9 patients); those with an abnormal electrocardiogram and advanced myocardial damage but without signs of congestive heart failure (26 patients); and those with an abnormal electrocardiogram together with congestive heart failure (17 patients). Of these patients, those with electrocardiographic abnormalities correspond to stages of the disease where advanced myocardial damage is proven. There was a 42% mortality during the follow-up of these patients.

According to the regression model, the value of the systolic blood pressure is a good predictor of mortality (P = 0.0380) in those with congestive heart failure. When we analyzed jointly the patients with an abnormal electrocardiogram, we found that several variables (systolic blood pressure, the presence of atrial fibrillation, the radiologic cardiothoracic index, and left ventricular end-diastolic volume obtained by the ventriculogram), were negatively correlated with regard to survival. This last model has a chi-square of 11.36 (P = 0.0228).

These models allow us to predict the prognosis in this group of patients with Chagas' disease and advanced myocardial damage. Such knowledge will help plan therapeutic strategies that may modify the course of the disease.

References (36)

  • F Pifano

    La miocardiopatia chagásica crónica en el medio rural venezolano

    Gaceta Med Caracas

    (1977)
  • K Kloetzel et al.

    Mortality in Chagas disease: life table for the period 1949–1967 in an unselected population

    Rev Inst Med Trop São Paulo

    (1969)
  • C Plugiesse et al.

    Estudo da sobrevida na miocardite crônica de Chagas descompensada

    Rev Inst Med Trop São Paulo

    (1976)
  • U Guajardo et al.

    Sobrevida y caracteristicas clínicas de la cardiopatia chagásica: seguimiento de 54 casos

    Rev Med Chile

    (1984)
  • A Rassi et al.

    Estudio clìnico, electrocardiogràfico e radiològico da cardiopatia chagàsica crônica: anàlise de 106 casos

    Rev Goiana Med

    (1956)
  • CC Porto

    O electrocardiograma no prognòstico e evoluçao da doença de Chagas

    Arq Bras Cardiol

    (1964)
  • JC Pinto et al.

    The prognosic value of the electrocardiographic features of chronic Chagas' disease

    Rev Inst Med Trop São Paulo

    (1968)
  • A Prata

    Natural history of chagasic cardiomyopathy

  • Cited by (44)

    • Etiological treatment of Chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events

      2015, Immunobiology
      Citation Excerpt :

      A major observation from the analysis of the cardiac group after Bz-therapy was that the overall complexity of the networks, as determined by the number of significant interactions, was similar to that observed in IND before treatment. These findings further support the hypothesis that there is a fine-tuning between all the mediators with major relevance to prevent the clinical progression of heart disease, as reported in other studies (Viotti et al. 2004; Viotti et al. 2004, 2006; Espinosa et al. 1991; Bestetti et al. 1994). In this context, Bz treatment not only may interrupt parasite replication but also induce new regulatory mechanisms, thus triggering a different host immune response (Laucella et al. 2009).

    • The prognostic significance of electrocardiographic changes in Chagas disease

      2012, Journal of Electrocardiology
      Citation Excerpt :

      The presence of complex ventricular arrhythmias, a peculiarity of this cardiomyopathy, translates into increased risk of sudden death and is a significant determining prognostic factor for survival.3,5,7 Echocardiography is an essential complementary method for evaluating ChCM, making it possible to determine the state of progress and the seriousness of the cardiac impairment, giving an estimate of the degree of left ventricle (LV) dysfunction and hence supplying fundamental data to guide therapy and prognosis.3,4,8-11 Standing out among the evaluated parameters are the presence of global systolic ventricular dysfunction of the LV measured by the left ventricular ejection fraction (LVEF), the occurrence of segment abnormalities, the presence of LV apical aneurysms, and an increase in the size and dysfunction of the right ventricle.3,12

    • Mortality indicators among chronic Chagas patients living in an endemic area

      2010, International Journal of Cardiology
      Citation Excerpt :

      Through this, adequate planning for measures to control the disease can be established. Several studies have attempted to determine which factors relating to chronic Chagas disease patients might serve as prognostic factors for the evolution of this disease [5,10–12,15–17]. Our study showed that eight variables were proven to be independent prognostic factors for mortality, in relation to the three types of death analysed.

    View all citing articles on Scopus

    This study was financed by the National Medicine Academy, Caracas, Venezuela.

    View full text